Provided by Tiger Trade Technology Pte. Ltd.

Charles River Laboratories

295.19
+3.741.28%
Post-market: 295.190.00000.00%19:38 EDT
Volume:887.56K
Turnover:262.16M
Market Cap:14.09B
PE:-60.47
High:298.18
Open:291.78
Low:289.07
Close:291.45
52wk High:299.32
52wk Low:144.26
Shares:47.74M
Float Shares:47.20M
Volume Ratio:1.02
T/O Rate:1.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.8814
EPS(LYR):-2.9122
ROE:-7.52%
ROA:4.11%
PB:4.96
PE(LYR):-101.36

Loading ...

Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jun 19

Charles River Laboratories International - Announces Collaboration With Lilly Tunelab

THOMSON REUTERS
·
Jun 18

Charles River teams with Lilly TuneLab to provide nonclinical testing for AI-driven drug discovery platform

Reuters
·
Jun 18

Press Release: Grace Therapeutics Announces 2026 Fiscal Year-End Financial Results, Provides Business Update

Dow Jones
·
Jun 18

Rothschild & Co Redburn Adjusts Charles River Laboratories International PT to $241 From $230, Maintains Buy Rating

MT Newswires Live
·
Jun 18

Charles River Laboratories Shares Rise After Morgan Stanley Upgrade

MT Newswires Live
·
Jun 18

Charles River Labs Raised to Overweight From Equal-Weight by Morgan Stanley

Dow Jones
·
Jun 17

Charles River upgraded to Overweight from Equal Weight at Morgan Stanley

TIPRANKS
·
Jun 17

Charles River Laboratories International Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Jun 17

Leerink sees favorable readthrough to Crinetics after Camurus’ Oclaiz CRL

TIPRANKS
·
Jun 11

Disc Medicine Provides Update from FDA Type A Meeting for Bitopertin in Erythropoietic Protoporphyria

GlobeNewswire
·
Jun 09

Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jun 09

Analysts Offer Insights on Healthcare Companies: Charles River Labs (CRL), Incyte (INCY) and Pfizer (PFE)

TIPRANKS
·
Jun 08

Charles River Laboratories International Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Jun 06

Analysts Are Bullish on Top Healthcare Stocks: Charles River Labs (CRL), TransMedics Group (TMDX)

TIPRANKS
·
Jun 06

RBC Capital Keeps Their Buy Rating on Charles River Labs (CRL)

TIPRANKS
·
Jun 06

Charles River Laboratories Has Potential to Outperform in 2H 2026, RBC Says

MT Newswires Live
·
Jun 05

Analysts Have Conflicting Sentiments on These Healthcare Companies: Amneal Pharmaceuticals (AMRX), Charles River Labs (CRL) and Axsome Therapeutics (AXSM)

TIPRANKS
·
Jun 04

Pharming announces U.S. FDA acceptance of sNDA resubmission for Joenja® (leniolisib) to treat children aged 4 to 11 years with APDS

GlobeNewswire
·
Jun 04

Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jun 04